At a glance
- Originator Maruko Seiyaku
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 24 Nov 1994 Discontinued-Preclinical for Diabetes mellitus in Japan (Unknown route)